March #186 : HPV Vaccine May Benefit Women With HIV - by Benjamin Ryan

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents


Achieving the End

Falling Through the Cracks

From the Editor

Let's Stay Together


Letters-March 2013


Opening New Doors

POZ Planet

Turn Up the Music


Country Remedy

Promoting PrEP

Native Talents

Bare Facts

All Dolled Up

Tickled Pink


The 360 Approach

Care and Treatment

See You in Six Months?

Studying Risk Factors for Mental Decline

Implementing Health Care Reform

Pregnant Women Struggling With Adherence

GMHC Treatment Issues March 2013

HPV Vaccine May Benefit Women With HIV

Research Notes

Prevention: Latino Epidemic Varies by Region

Treatment: Atripla vs. Stribild and Complera

Cure: A Cat-and-Mouse Vaccine Game

Concerns: Ex-Inmates Aren’t Retained in Care

POZ Survey Says

Listen to Your Heart

POZ Heroes

Farewell, Friend

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

March 2013

HPV Vaccine May Benefit Women With HIV

by Benjamin Ryan

HIV-positive women may benefit from the human papillomavirus (HPV) vaccine, in particular the more than 45 percent of young women who haven’t been exposed to the higher-risk types of the virus.

In a National Institutes of Health study of 99 HIV-positive women between the ages of 16 and 23, published in the Journal of Acquired Immune Deficiency Syndromes, researchers found that three quarters of the women were infected with at least one type of HPV. However, when they looked at the two high-risk forms of the virus that cause 70 percent of cervical cancers, only a respective 12 and 5 percent of the study group were infected.

“The findings suggest that vaccinating even sexually active HIV-positive women could prevent cervical cancer,” said the study’s lead author, Jessica A. Kahn, MD, MPH, a professor of pediatrics at Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine.

As for the three-shot vaccine’s $400 price tag (which doesn’t include the cost of office visits), public insurance programs tend to reimburse for females up to age 18, and private insurers to age 26. However, some health providers do partner with the vaccine manufacturer to provide the shots for free.  

Search: HIV, positive women, HPV vaccine, HPV vaccine and benefits, cervical cancer

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.